Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study

AIMS/INTRODUCTION: Differences in the glucose‐lowering mechanisms of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have been noted. Clarifying these differences could facilitate the choice of optimal drugs for individuals with type 2 diabetes and requires investigation in a clinical setting....

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwata, Hitoshi, Yabe, Daisuke, Murotani, Kenta, Fujiwara, Yuuka, Haraguchi, Takuya, Kubota, Sodai, Kubota‐Okamoto, Saki, Usui, Ryota, Ishitobi, Minori, Yamazaki, Yuji, Hamamoto, Yoshiyuki, Kurose, Takeshi, Seino, Yusuke, Yamada, Yuichiro, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668059/
https://www.ncbi.nlm.nih.gov/pubmed/34022121
http://dx.doi.org/10.1111/jdi.13598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668059/
https://www.ncbi.nlm.nih.gov/pubmed/34022121
http://dx.doi.org/10.1111/jdi.13598

Ejemplares similares